Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 27 peer-reviewed journal articles Updated
Nephrology · TSC2/PKD1 Contiguous Gene Deletion Syndrome

Surveillance Guidelines and Emergency Red Flags

At a Glance

People with TSC2/PKD1 contiguous gene deletion syndrome need lifelong monitoring of kidney function, blood pressure, seizures, and development. A seizure lasting 5 minutes or more, kidney bleeding, or rising pressure in the brain require immediate emergency care.

Living with TSC2/PKD1 contiguous gene deletion syndrome (CGS) requires a commitment to lifelong, proactive monitoring. Because this syndrome combines two conditions, your care team will use a specialized “surveillance map” to watch for changes in the kidneys, brain, and development [1][2]. While the goal is to catch issues early when they are most manageable, it is equally important to recognize “red flags” that require immediate emergency intervention.

An Individualized Surveillance Framework

There is no single, universally validated surveillance schedule for this specific rare deletion. Standard care for CGS follows the International Tuberous Sclerosis Complex (TSC) consensus but is often individualized and intensified due to the more aggressive nature of the kidney disease [3][4]. Your nephrologist and neurologist will set the actual schedule based on age, kidney function, tumor burden, and whether sedation is required for imaging.

Area of Focus Typical Framework What It Involves
Kidney Imaging Usually more frequent than standard TSC (e.g. every 6–12 months)* Ultrasound is useful to monitor cyst growth, but MRI (often without contrast) is preferred for a detailed look and precise measurement of tumors (AMLs) and kidney volume [5][1].
Kidney Labs Individualized by Nephrologist Checking serum creatinine/eGFR, urine protein/albumin, electrolytes, and monitoring for chronic kidney disease complications (like anemia). Imaging alone does not show how well the kidneys are filtering [3][1].
Blood Pressure Every visit + ABPM Manual BP checks at every visit. An Ambulatory Blood Pressure Monitor (a 24-hour wearable device) is highly useful, though the frequency depends on age, cuff fit, and the clinician’s assessment [6][2].
Brain MRI Every 1–3 years until age 25 Screening for SEGA (brain tumors) in asymptomatic individuals. The schedule must be adjusted if a SEGA is known or changing [7][8].
Epilepsy (EEG) Baseline & As Needed Baseline and follow-up intervals depend on age, findings, and specialist assessment. An EEG detects electrical abnormalities but does not replace caregiver observation [9][10].
Psychiatric (TAND) At least Annually Screening for TSC-Associated Neuropsychiatric Disorders using the TAND Checklist [11][12]. The checklist is a screening tool, not a formal diagnostic assessment; positive concerns should lead to formal evaluation.
Eyes & Skin Annually Baseline eye exam and skin checks for TSC-related spots or growths [2][13].

*Frequency for CGS is often more frequent than the standard 1–3 years for isolated TSC [1].

Emergency Red Flags: When to Seek Immediate Care

While most aspects of CGS are managed through routine appointments, certain complications are true medical emergencies. If you see these signs, follow your emergency plan and seek immediate care.

1. Status Epilepticus (Prolonged Seizures)

A seizure that lasts too long or occurs in rapid succession without recovery is an emergency.

  • Red Flags: Any seizure lasting 5 minutes or longer, or multiple seizures occurring back-to-back [14].
  • Action: Follow your “Seizure Action Plan.” Give the prescribed rescue medicine (like midazolam) at the instructed time, and call emergency services (911) immediately. Do not wait to see if the medicine works before calling [14][15].
  • First Aid: Time the seizure, place the person on their side if possible, and protect them from injury. Never put anything in the mouth or restrain them.
  • Note: Suspected new infantile spasms also require urgent, same-day neurologic assessment.

2. Renal AML Hemorrhage (Bleeding)

Because the kidneys in CGS can contain large angiomyolipomas (AMLs), there is a risk of sudden bleeding into the kidney or the surrounding space (Wunderlich syndrome) [16][17].

  • Red Flags: Sudden, severe pain in the abdomen, side, or back; visible blood in the urine (hematuria); extreme paleness, fainting, or a rapid heart rate [17][18].
  • Action: Immediate emergency care is required. Doctors often use selective embolization to block the bleeding blood vessel. Embolization is common, but it is not guaranteed to be sufficient, and emergency surgery may sometimes be needed [19][20].

3. SEGA and Obstructive Hydrocephalus

A SEGA tumor can grow near the pathways that drain fluid from the brain. If it blocks this flow, pressure builds up rapidly (obstructive hydrocephalus) [21][22].

  • Red Flags: A “new” or worsening headache that is unusually severe; repeated, forceful vomiting (especially in the morning); blurry or double vision; or a sudden change in personality or consciousness [23][24].
  • Action: This requires urgent neurosurgical evaluation. Treatment may involve a temporary drain to relieve pressure or surgical removal of the tumor [25][26].

These are specific examples, not an exhaustive list. Severe symptomatic hypertension, markedly reduced urine, severe dehydration, breathing difficulty, or fever/suspected infection also warrant urgent medical attention.

The Importance of TAND Screening

It is easy to focus only on scans and blood pressure, but TAND (neuropsychiatric) symptoms often have the biggest impact on daily life [12]. Use the TAND Checklist at every annual visit to talk to your doctor about mood, behavior, and school progress [11]. Early intervention for autism, ADHD, or learning disabilities is just as critical as managing a kidney cyst or a brain tumor [2][27].

Common questions in this guide

How often should kidney imaging be done in TSC2/PKD1 deletion syndrome?
There is no single schedule for this rare deletion syndrome. Kidney imaging is often more frequent than for tuberous sclerosis complex alone, sometimes every 6–12 months, but the nephrologist should adjust it for age, kidney function, tumor burden, and whether sedation is needed. MRI gives a detailed view of angiomyolipomas and kidney volume, while ultrasound can help track cysts.
Which tests show whether the kidneys are working well?
Blood tests for creatinine and estimated filtration rate, urine protein or albumin testing, and electrolyte checks help assess kidney function and complications such as anemia. Blood pressure monitoring is also important. Scans show cysts, tumors, and kidney size, but they do not show how well the kidneys filter blood.
When should I call emergency services for a seizure?
Call emergency services for any seizure that lasts 5 minutes or longer or for repeated seizures without recovery between them. Follow the person's seizure action plan and give prescribed rescue medicine at the instructed time; do not wait to call to see whether it works. Time the seizure, keep the person safe, place them on their side if possible, and never put anything in their mouth or restrain them.
What are the warning signs of bleeding from a kidney angiomyolipoma?
Sudden severe pain in the abdomen, side, or back, visible blood in the urine, extreme paleness, fainting, or a rapid heartbeat can signal bleeding from a kidney angiomyolipoma. This is an emergency and requires immediate medical care. Doctors may stop the bleeding with selective embolization, but emergency surgery may sometimes be needed.
Which symptoms could mean a SEGA is causing dangerous pressure in the brain?
A new or worsening severe headache, repeated forceful vomiting—especially in the morning—blurred or double vision, or a sudden change in personality or consciousness can be warning signs. These symptoms may indicate that a SEGA brain tumor is blocking normal fluid drainage and require urgent neurosurgical evaluation.
What does the TAND checklist screen for?
The TAND checklist is an annual screening tool for mood, behavior, and school or developmental progress in people with tuberous sclerosis complex. It can highlight concerns such as autism, ADHD, or learning disabilities, but it is not a formal diagnosis. Positive concerns should lead to a full developmental, psychological, or psychiatric evaluation so support can begin early.

Get notified when new evidence is published on Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (27)
  1. 1

    Progressive Polycystic Kidney Disease in an Infant Girl With TSC2/PKD1 Contiguous Gene Syndrome.

    Hashimoto K, Hayashida T, Otsubo Y, et al.

    Cureus 2024; (16(8)):e67800 doi:10.7759/cureus.67800.

    PMID: 39323690
  2. 2

    Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations.

    Northrup H, Aronow ME, Bebin EM, et al.

    Pediatric neurology 2021; (123()):50-66 doi:10.1016/j.pediatrneurol.2021.07.011.

    PMID: 34399110
  3. 3

    Tuberous sclerosis complex-associated kidney disease in children.

    Marlais M, Mekahli D

    Pediatric nephrology (Berlin, Germany) 2025; (40(6)):1871-1877 doi:10.1007/s00467-024-06642-9.

    PMID: 39814976
  4. 4

    Diagnosis and genotype-phenotype correlation in patients with PKD1/TSC2 contiguous gene deletion syndrome.

    Shang S, Mei Y, Wang T, et al.

    Clinical nephrology 2022; (97(6)):328-338 doi:10.5414/CN110476.

    PMID: 35142283
  5. 5

    Imaging of Kidney Cysts and Cystic Kidney Diseases in Children: An International Working Group Consensus Statement.

    Gimpel C, Avni EF, Breysem L, et al.

    Radiology 2019; (290(3)):769-782 doi:10.1148/radiol.2018181243.

    PMID: 30599104
  6. 6

    Blood pressure and glomerular filtration rate in youth with tuberous sclerosis complex.

    Vargiami E, Stabouli S, Sidira C, et al.

    European journal of pediatrics 2022; (181(4)):1465-1472 doi:10.1007/s00431-021-04333-3.

    PMID: 34988664
  7. 7

    Subependymal Giant Cell Astrocytoma Size Measurement in Tuberous Sclerosis Complex: Noncontrast vs Contrast-Enhanced 3-Dimensional T1-Weighted Magnetic Resonance Imaging (MRI).

    Hill BJ, Gadde JA, Palasis S

    Journal of child neurology 2019; (34(14)):922-927 doi:10.1177/0883073819867541.

    PMID: 31424303
  8. 8

    Natural History and Current Treatment Options for Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis Complex.

    Jóźwiak S, Mandera M, Młynarski W

    Seminars in pediatric neurology 2015; (22(4)):274-81.

    PMID: 26706014
  9. 9

    Early epileptiform EEG activity in infants with tuberous sclerosis complex predicts epilepsy and neurodevelopmental outcomes.

    De Ridder J, Verhelle B, Vervisch J, et al.

    Epilepsia 2021; (62(5)):1208-1219 doi:10.1111/epi.16892.

    PMID: 33778971
  10. 10

    Electrographic-only seizures and status epilepticus in neonates with Tuberous Sclerosis Complex.

    Pellegrin S, Mastrangelo M, Accorsi P, et al.

    Pediatric research 2026; doi:10.1038/s41390-026-05074-5.

    PMID: 42162280
  11. 11

    International consensus recommendations for the identification and treatment of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).

    de Vries PJ, Heunis TM, Vanclooster S, et al.

    Journal of neurodevelopmental disorders 2023; (15(1)):32 doi:10.1186/s11689-023-09500-1.

    PMID: 37710171
  12. 12

    TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study.

    de Vries PJ, Belousova E, Benedik MP, et al.

    Orphanet journal of rare diseases 2018; (13(1)):157 doi:10.1186/s13023-018-0901-8.

    PMID: 30201051
  13. 13

    TSC2/PKD1 contiguous deletion syndrome in a pregnant woman: A case report.

    Huang S, Xu K, Xu Y, et al.

    Frontiers in medicine 2023; (10()):1101079 doi:10.3389/fmed.2023.1101079.

    PMID: 36895714
  14. 14

    Association of Child Neurology (AOCN) - Indian Epilepsy Society (IES) Consensus Guidelines for the Diagnosis and Management of West Syndrome.

    Sharma S, Kaushik JS, Srivastava K, et al.

    Indian pediatrics 2021; (58(1)):54-66.

    PMID: 33452776
  15. 15

    Epileptic spasms - 175 years on: Trying to teach an old dog new tricks.

    Wilmshurst JM, Ibekwe RC, O'Callaghan FJK

    Seizure 2017; (44()):81-86 doi:10.1016/j.seizure.2016.11.021.

    PMID: 27989601
  16. 16

    Renal angiomyolipoma bleeding in a patient with TSC2/PKD1 contiguous gene syndrome after 17 years of renal replacement therapy.

    Furlano M, Barreiro Y, Martí T, et al.

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 2017; (37(1)):87-92 doi:10.1016/j.nefro.2016.04.007.

    PMID: 27595512
  17. 17

    Wünderlich Syndrome Without Classic Signs: A Case of Spontaneous Retroperitoneal Hemorrhage From a Ruptured Renal Angiomyolipoma.

    Andino-Colón C, Nuñez A, Poventud Y, Mercado J

    Cureus 2026; (18(3)):e106094 doi:10.7759/cureus.106094.

    PMID: 41918546
  18. 18

    Management Outcomes of Large Renal Angiomyolipoma Presenting with Wunderlich Syndrome-Experience from a Tertiary Center.

    Pal AK, Kalra S, Sreenivasan SK, et al.

    Journal of kidney cancer and VHL 2023; (10(2)):21-28 doi:10.15586/jkcvhl.v10i2.265.

    PMID: 37303946
  19. 19

    Urgent Transcatheter Arterial Embolization for Wunderlich Syndrome With Hypovolemic Shock Secondary to Ruptured Renal Angiomyolipoma.

    Gong M, Liu Z, Su H, et al.

    Frontiers in surgery 2021; (8()):704478 doi:10.3389/fsurg.2021.704478.

    PMID: 34485374
  20. 20

    Endovascular treatment of intrarenal aneurysms bleeding and angiomyolipomas in a patient with tuberous sclerosis and polycystic kidney disease.

    Leite T, Pazinato LV, Vidal MJA, et al.

    Jornal brasileiro de nefrologia 2023; (45(1)):111-115 doi:10.1590/2175-8239-JBN-2021-0023.

    PMID: 34328493
  21. 21

    Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA).

    Ebrahimi-Fakhari D, Franz DN

    Expert opinion on pharmacotherapy 2020; (21(11)):1329-1336 doi:10.1080/14656566.2020.1751124.

    PMID: 32338549
  22. 22

    [Hemorrhagic Onset of Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis:A Case Report and Review of Literature].

    Adachi M, Nakamura M, Shinozaki N, Miyazaki T

    No shinkei geka. Neurological surgery 2017; (45(5)):397-404 doi:10.11477/mf.1436203521.

    PMID: 28490681
  23. 23

    Successful resection of large subependymal giant cell astrocytoma using presurgical mammalian target of rapamycin inhibitor.

    Kawabe M, Ichikawa H, Nagai K, et al.

    Surgical neurology international 2025; (16()):332 doi:10.25259/SNI_159_2025.

    PMID: 41030394
  24. 24

    The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).

    Weidman DR, Palasamudram S, Zak M, et al.

    Journal of neuro-oncology 2020; (147(3)):731-736 doi:10.1007/s11060-020-03487-8.

    PMID: 32285309
  25. 25

    [Subependymal Giant Cell Astrocytoma with Tuberous Sclerosis Complex(TSC-SEGA)].

    Ichikawa T, Niida Y

    No shinkei geka. Neurological surgery 2022; (50(1)):111-121 doi:10.11477/mf.1436204536.

    PMID: 35169091
  26. 26

    Acute Management of Symptomatic Subependymal Giant Cell Astrocytoma With Everolimus.

    Arroyo MS, Krueger DA, Broomall E, et al.

    Pediatric neurology 2017; (72()):81-85 doi:10.1016/j.pediatrneurol.2017.04.008.

    PMID: 28511812
  27. 27

    Tuberous sclerosis-associated neuropsychiatric disorders: a paediatric cohort study.

    Toldo I, Brasson V, Miscioscia M, et al.

    Developmental medicine and child neurology 2019; (61(2)):168-173 doi:10.1111/dmcn.14055.

    PMID: 30298907

This page is for informational purposes only and does not constitute medical advice. Your nephrologist, neurologist, and emergency team should tailor surveillance and emergency plans to your situation.

Guide contents Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis
Research & Literature
04 Standard of Care and Medical Management 06 Building Your Care Team and Preparing for Visits